Action CNBX CANNABICS PHARMACEUTICALS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Cannabics Pharmaceuticals Inc. Other OTC

Actions

CNBX

US13764M1009

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)
CNBX Pharmaceuticals Inc. Announces Board Resignations
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CNBX
  4. Action CNBX
  5. Actualités Cannabics Pharmaceuticals Inc.
  6. Autres langues